News
EQS-Adhoc: Deutsche Konsum REIT-AG: Deutsche Konsum REIT-AG enters into an agreement on restructuring capital increase
Fuller, Smith & Turner PLC: Transaction in own shares
Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Trade Tensions Reshaping U.S. Corporate Strategy, HSBC Survey Finds
U.S. companies remain optimistic about future international expansion despite facing cost pressures, disrupted supply chains and ongoing uncertainty more acutely when compared to global peers
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
EQS-News: InTiCa Systems SE: Interim report for Q1 2025 published – Subdued start, improvement only expected in the second half of the year
EQS-News: Verve achieves 32% Revenue and 37% Adjusted EBITDA Growth in Q1 2025 - Publishing FY 2025 Guidance
CDB Aviation Subsidiary CDBL FUNDING 1 Prices USD 700 Million Dual-Tranche Senior Unsecured Notes
CDBL FUNDING 1, a wholly owned subsidiary of CDB Aviation Lease Finance Designated Activity Company (“CDB Aviation”), successfully priced a dual-tranche offering of senior unsecured notes (the
Median Technologies to Showcase iCRO’s Central and AI-Powered Imaging Services for Oncology Clinical Trials at ASCO 2025
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software
EQS-News: Medios AG Annual General Meeting 2025: Shareholders approve all proposed resolutions
Westwater Resources Announces Successful Patent Application for the Kellyton Graphite Plant
Westwater Resources, Inc. (NYSE American: WWR) an energy technology and battery-grade natural graphite development company, today announced it received a Notice of Allowance from the U.S. Patent
Verve Invites Investors to the Presentation of its Interim Report Q1 2025 on May 28, 2025 at 10:00am CEST
EQS-News: aconnic reduces emissions by 30% in 2024 and improves sustainability rating with Carbon Disclosure Project (CDP)
EQS-News: Australia's largest telecommunications company equips first transmission masts with self-sufficient hydrogen system from H2 Core AG
EQS-News: Weng Fine Art AG: ARTNET STAKE SOLD FOR € 15.2 MILLION
EQS-News: tick Trading Software AG reorganizes sales and customer management
Mitsui Chemicals lanciert neuen Corporate Venture Capital Fund „321Catalyst™“
Mitsui Chemicals, Inc. (Tokio: 4183; Präsident und CEO: Osamu Hashimoto), ein globaler Chemiehersteller mit Sitz in Japan, gab heute die Gründung seines zweiten Corporate Venture Capital Fund
From Albania to Burundi...a day for little heroes: Fix&Foxi TV & SOS Children's Villages worldwide celebrate International Children's Day
EQS-News: Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma
EQS-News: InTiCa Systems SE: Annual report for 2024 published – Provisional figures confirmed
EQS-News: Beowolff Capital Announces to Launch Voluntary Public Takeover and Delisting Offer for artnet AG
EQS-Adhoc: artnet AG: SCUR-Alpha 1849 GmbH (in future: Leonardo Art Holdings GmbH) announces takeover and delisting offer based on an investment and delisting agreement with artnet AG
Mitsui Chemicals Launches New Corporate Venture Capital Fund ‘321Catalyst™’
Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu), a global chemicals manufacturer based in Japan, today announced the launch of its second Corporate Venture Capital Fund